New Enterprise Associates 12, Limited Partnership
CIK 1383391 · last filed 2020-06-12
New Enterprise Associates 12, Limited Partnership is a corporate insider who has filed 30 SEC Form 4 insider transactions across 12 companies since 2011. The most recent filing, for ARDX, was dated Jun 12, 2020. Across all open-market trades the lifetime net is −$299.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $699.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$699.04M
12
30
-$299.74M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARDX | 10%+ Owner | 8,086,401 | $4.00 | $32.35M | $95.00M | 5 | 2020-06-12 |
| Tintri, Inc. (TNTR) Delisted | 10%+ Owner | 2,724,795 | — | — | $6.49M | 1 | 2017-07-10 |
| Zosano Pharma Corp (ZSAN) Delisted | 10%+ Owner | 3,029 | $0.56 | $1.7K | -$11.6K | 1 | 2016-08-26 |
| TREVENA INC (TRVN) Delisted | 10%+ Owner | 7,699 | $0.01 | $85 | $40.00M | 1 | 2014-12-10 |
| Viracta Therapeutics, Inc. (SNSS) Delisted | 10%+ Owner | 1,331,238 | $18.62 | $24.79M | -$8.51M | 1 | 2014-08-29 |
| CHANNELADVISOR CORP (ECOM) Delisted | 10%+ Owner | 1,661,357 | $23.09 | $38.36M | -$321.70M | 1 | 2013-11-13 |
| GRPN | 10%+ Owner | 2,709,248 | $25.03 | $67.81M | $0 | 2 | 2013-09-17 |
| WDAY | 10%+ Owner | 2,321,212 | $179.64 | $416.98M | $0 | 1 | 2013-04-11 |
| FUSION-IO, INC. (FIO) Delisted | 10%+ Owner | 9,058,379 | — | — | -$122.74M | 14 | 2012-09-06 |
| HYPERION THERAPEUTICS INC (HPTX) Delisted | 10%+ Owner | 2,206,740 | — | — | $15.00M | 1 | 2012-08-02 |
| ECHO | 10%+ Owner | 2,020,219 | $90.04 | $181.90M | $0 | 1 | 2012-03-01 |
| ARYx Therapeutics, Inc. (ARYX) Delisted | 10%+ Owner | 0 | — | — | -$3.26M | 1 | 2011-03-14 |
Recent Filings
30 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-06-12 | ARDX | Other (J) | −1,482,809 | $0 | EDGAR |
| 2019-12-09 | ARDX | Grant (A) | +1,200,000 | $7.50M | EDGAR |
| 2017-07-10 | Tintri, Inc. (TNTR) Delisted | Mixed | +5,248,359 | $6.49M | EDGAR |
| 2016-08-26 | Zosano Pharma Corp (ZSAN) Delisted | Sell (S) | −9,600 | -$11.6K | EDGAR |
| 2016-07-20 | ARDX | Buy (P) | +2,290,950 | $20.00M | EDGAR |
| 2016-01-14 | ARDX | Buy (P) | +1,500,000 | $15.00M | EDGAR |
| 2015-06-09 | ARDX | Buy (P) | +5,607,477 | $60.00M | EDGAR |
| 2014-12-10 | TREVENA INC (TRVN) Delisted | Buy (P) | +10,000,000 | $40.00M | EDGAR |
| 2014-08-29 | Viracta Therapeutics, Inc. (SNSS) Delisted | Sell (S) | −1,066,800 | -$8.51M | EDGAR |
| 2013-11-13 | CHANNELADVISOR CORP (ECOM) Delisted | Sell (S) | −9,938,169 | -$321.70M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.